News

According to BioImagene, Virtuoso is a role-based system that enables pathologists, histo-technologists, lab administrators and clinicians to improve the efficiency and quality of the anatomical pathology workflow. It

Biophan Technologies, a developer of next-generation medical technology, has received a new patent from the US Patent and Trademark Office that covers important operational aspects of the Myotech

The aggregate purchase price is $33 million, subject to certain adjustments. At MannKind’s option, up to $30 million worth of the company’s common stock may be issued to

Mr Contamine was previously senior executive vice president, deputy general manager and CFO of Veolia Environment. Mr Contamine is a graduate of Ecole Polytechnique (X), and ENSAE, the

The application for the drug was submitted by Ranbaxy from the Ohm Laboratories manufacturing facility, located in North Brunswick, New Jersey, US. The office of generic drugs, FDA,

According to the company, Acanya gel is the only FDA-approved fixed combination antibiotic and benzoyl peroxide (BPO) medication for once-daily treatment of both non-inflammatory and inflammatory lesions of

Origen will use its avian transgenic technology to develop transgenic chickens, which can be immunized with any disease target of interest, including diseases such as cancer and autoimmunity.

In his previous position, Dr Lanthaler served as CFO of Intercell in Vienna, Austria, a biopharmaceutical company. In this role, Dr Lanthaler was also responsible for business development

Proceeds will be used to support future growth initiatives, including product acquisitions. As part of the transaction, Victory announced that Scott Barry, Essex Partner, has joined its board